Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma

Clinical trial NCT00715793 · COMPLETED

Trial details

NCT number: NCT00715793
Sponsor: Hussein Tawbi
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2008-06-01
Primary completion: 2015-05-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.